What it is
Thinning hair (alopecia) describes a progressive reduction in hair density, shaft diameter, or coverage.
Progressive reduction in hair density or shaft diameter — ranging from androgenetic pattern hair loss to telogen effluvium, hormonal change, and nutritional deficiency.

At a glance
What it is
Thinning hair (alopecia) describes a progressive reduction in hair density, shaft diameter, or coverage.
Commonly experienced as
Evidence context
Safety
See staying safeContext
Thinning hair encompasses a reduction in hair density, strand thickness, or coverage visible to the individual or on examination. It is distinct from focal patchy loss (alopecia areata) and scarring alopecia, though these may overlap. Androgenetic alopecia (AGA) — male and female pattern hair loss — is the most common cause, driven by androgenic miniaturisation of hair follicles with a strong genetic component. Telogen effluvium is diffuse thinning 2–4 months after a systemic stressor (illness, surgery, childbirth, severe weight loss, high psychological stress) as follicles prematurely enter resting phase. Hypothyroidism, iron deficiency, zinc deficiency, and biotin deficiency are important reversible nutritional causes. Polycystic ovary syndrome drives androgen-mediated thinning in women. Certain medications (valproate, isotretinoin, warfarin, chemotherapy) cause thinning.
The Evidence
What the research says about causes, reversibility, and the options with the strongest support — from clinical to complementary.
Many causes of thinning hair are identifiable and reversible
Thinning hair has well-researched causes ranging from genetics and hormones to nutritional deficiencies and systemic stress. Several interventions have strong clinical evidence, and some complementary approaches show emerging support — though quality varies considerably.
Rapid diffuse shedding after major illness, surgery, or severe stress warrants assessment even if spontaneous recovery is likely. Thinning alongside fatigue, cold intolerance, or weight change may indicate thyroid dysfunction. In younger women, thinning with menstrual irregularity and acne should prompt screening for PCOS. These are not reasons to panic — but they are reasons to see a qualified practitioner.
Minoxidil (topical or oral) is first-line for androgenetic alopecia with robust clinical trial support — worth discussing with a practitioner to assess suitability. Oral finasteride has strong evidence in men but carries a meaningful side-effect profile. Correcting iron deficiency, thyroid dysfunction, or zinc deficiency may support recovery of hair density where these are the underlying cause. Low-level laser therapy and platelet-rich plasma injections have emerging but more limited evidence.
Finasteride is absolutely contraindicated in women of childbearing potential due to teratogenic risk — this is a hard clinical boundary, not a precaution. He shou wu (fo-ti), used in traditional Chinese medicine for hair and ageing, has documented cases of serious liver injury. Anyone considering it should make an informed decision with awareness of this risk, ideally with practitioner guidance.
Ayurveda uses scalp oil treatments with herbs such as bhringraj, amla, and brahmi, alongside dietary support. Bhringraj has been studied in limited preliminary research, though evidence quality is low. Some preliminary research has compared rosemary oil applied topically to low-dose minoxidil, with mixed results — promising but not yet definitive. TCM approaches focus on systemic nourishment; he shou wu is traditional but carries hepatotoxicity risk requiring caution.
Telogen effluvium often resolves without intervention once the triggering stressor is addressed, typically within 6–12 months. Nutritional causes respond well to targeted supplementation when a deficiency is confirmed. Androgenetic alopecia is chronic and benefits from sustained evidence-based management. For complementary approaches, identifying whether thinning is effluvium, androgenetic, or nutritional in origin matters — the appropriate supporting strategy differs meaningfully by cause.
Many supplements marketed for hair growth — including high-dose biotin — lack robust evidence in people without a confirmed deficiency. PRP and LLLT show promise but study sizes remain small and protocols vary. Traditional herbal approaches are often under-researched by modern standards. Absence of strong evidence does not mean an approach is ineffective, but it does mean inflated outcome claims should be viewed critically.
Safety first
General, informational guidance — not diagnostic. A qualified practitioner can advise on your own situation.
Featured
These practitioners have chosen to be featured on Gyfts.
Read next
References
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Browse verified practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.